Establishment Labs Holdings Inc, a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announces it will host a virtual symposium on October 21, 2020, to present 10 years of worldwide clinical and real-world data for its Motiva silicone breast implants.
The event, “Motiva: A Decade of Contributions to Women’s Health,” will take place October 21 from 2 pm to 3pm EST.
It will feature presentations by members of the Company’s Medical Advisory Board, Scientific Advisory Board and independent plastic surgeons who will speak about their clinical data and long-term experiences using the Company’s innovative products.
Panel members scheduled to participate include Brian Kinney, MD, FACS; Prof. Marcos Sforza, MD; Dennis Hammond, MD, FACS; Charles Randquist, MD; Giovanni Botti, MD; and Manuel Chacón, MD. The symposium will also include remarks by Caroline Glicksman, MD, FACS, Medical Director for the Motiva Implants U.S. clinical trial, which is studying the safety and effectiveness of the Motiva Implants SmoothSilk Round and Ergonomix silicone gel-filled breast implants in augmentation, reconstruction and revision surgery.
[Source(s): Establishment Labs Holdings Inc, Globe Newswire]
Related Content:
Study Details New Advancements in Hybrid Breast Reconstruction Technique Using Motiva Ergonomix Implants
